Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)

Chris P. Verschoor, Laura Haynes, Graham Pawelec, Mark Loeb, Melissa K. Andrew, George A. Kuchel, Janet E. McElhaney

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)
Original languageEnglish
Article number718966
JournalFrontiers in Aging
Volume2
DOIs
Publication statusPublished - 2021

ASJC Scopus Subject Areas

  • Ageing
  • Genetics
  • Molecular Biology
  • Physiology

Keywords

  • cell-mediated immune responses
  • cytomegalovirus
  • frailty index
  • granzyme B
  • high-dose vs. standard-dose split-virus influenza vaccine
  • interferon-gamma
  • interleukin-10
  • older adults

Fingerprint

Dive into the research topics of 'Corrigendum: Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults (Frontiers in Aging, (2021), 2, (649110), 10.3389/fragi.2021.649110)'. Together they form a unique fingerprint.

Cite this